Search

everythinglearnresearchcommunity

for

Search:↓

Clascoterone's full trial results are expected by mid-July 2026, but skepticism exists about timely release. Clascoterone is available at 5% from some telehealth companies.

The user has been using finasteride (1mg) and minoxidil (3mg) since mid-September and is concerned about continued hair shedding. They are seeking opinions on whether this is normal.

The user has been taking 2.5 mg of oral minoxidil daily since mid-January and has used finasteride for about five years, noting a decrease in its effectiveness. They are questioning whether their hair appears thicker due to minoxidil or if it's just longer.

The user experienced noticeable hair regrowth after starting dutasteride and minoxidil in mid-November. Despite mixed opinions, many users encouraged patience and consistency with the treatment.

The user had a hair transplant with 2000 grafts in the frontal and mid-scalp areas and has been using finasteride and minoxidil for 3 months. The crown area is expected to improve with continued treatment, and results are generally positive so far.

The user experienced good crown progress in 3 months using finasteride, collagen, vitamins B, C, D, zinc, and dermarolling. They are pleased with the results after a hair transplant on the front and mid scalp.

The user has been using finasteride since late 2021 and added oral minoxidil in mid-2024, considering adding dutasteride for better results. Users discuss the effectiveness and side effects of these treatments, with some recommending ketoconazole shampoo for redness.

A hair restoration case involved injecting four different doses of Verteporfin into the mid scalp and using Scalp MicroPigmentation (SMP) around the extraction areas. Photos were taken and an update will be shared soon.

Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.

Finasteride worked better for frontal scalp hair loss, while dutasteride helped the crown and mid-scalp but worsened the frontal area. The user shared personal experiences and invited open dialogue.

A user reported noticeable hair regrowth after using 5% topical minoxidil daily and microneedling weekly since mid-January. They previously used dutasteride for four years with minimal effect.

The conversation is about someone experiencing slow but steady hair regrowth using topical Minoxidil and 1mg Finasteride daily since mid-December. Another person commented positively on the progress.

A 31-year-old man shared his 2-year experience using finasteride and minoxidil after a hair transplant on the front and mid scalp, noting improvement but still having a thin crown. He recently started dermastamping, plans to use ketoconazole shampoo, and uses hair fibers for extra confidence at events.

Breezula, a topical treatment, is anticipated to be available in the US by mid-2027 as a potential alternative to finasteride with fewer systemic side effects. There is ongoing debate about its effectiveness and some users report similar side effects to finasteride.

The FDA will now require only one clinical trial for drug approval, potentially speeding up the release of hair loss treatments like PP405. Pelage is expected to present full results of PP405 Phase 2a trials and move to Phase III in mid-2026.

Hair loss has slowed or stopped after 5 months of daily oral minoxidil and finasteride treatment, with ketoconazole shampoo used twice a week. Noticeable thickening is observed, especially on the mid scalp.

PP405 may induce new hair growth but cannot revive completely dead follicles, and its effectiveness on hairlines is uncertain. It is expected to be available by mid-2028, but users are advised to manage expectations and consider using other treatments like minoxidil and finasteride.

A user shared their positive experience with a 2987 graft hair transplant focused on the hairline, supplemented by finasteride and minoxidil for the mid scalp and crown. They expressed satisfaction with the results and the supportive care received during and after the procedure.

The user is unhappy with the results of their second hair transplant, feeling that grafts were wasted on an already transplanted hairline instead of increasing mid-scalp density. They regret stopping medications like Dutasteride, Minoxidil, and RU58841, which led to significant hair loss, and plan to restart them.

A 34-year-old from Patna shared a 5-month update on his hair transplant, which involved 4,200 grafts using the FUE technique to cover the front and mid-scalp. He experienced initial shock loss but now sees natural-looking growth and improved density.

The user followed a hair loss treatment routine using liquid minoxidil, oral minoxidil, and oral finasteride, with plans to stop topical minoxidil by mid-2026. They experienced significant improvement, especially in the crown area, after starting oral minoxidil.

The user shared a 6-month progress update on hair loss treatment using Dutasteride (0.5mg), Minoxidil (5%), and Dermanator 2. They reported improved hair density and coverage, especially in the crown/mid-scalp, and are focusing on enhancing the hairline.

A user shared their positive experience 5 months after a hair transplant, emphasizing the importance of thorough research and using finasteride and minoxidil to control hair loss. They had 3700 grafts transplanted to the front/mid-scalp and used medications to fill in the crown.

Oral minoxidil and spironolactone helped restore the hairline but not the scalp behind it. Hairline and temples often respond first to treatment, with mid-scalp and crown following later.

Choosing between good and great hair transplant surgeons, considering factors like wait times, costs, and potential risks of mid-tier clinics. The user is contemplating whether to opt for a reputable clinic in Cancun or save for an elite surgeon.

A 50-year-old user shares progress on hair loss treatment after 4 months using finasteride and minoxidil, along with 2 laser sessions with exosomes. The user hopes to restore the crown and mid-scalp areas.

After 8 months of using oral Minoxidil 5mg and Finasteride 1mg, the user still experiences hair loss, particularly miniaturized hairs in the mid-scalp area, along with itching. They are concerned about losing around 40 hairs daily despite treatment.

A 21-year-old shares their one-year progress using finasteride for hair loss, experiencing initial shedding but eventual regrowth, especially on the crown. They consider switching to dutasteride due to continued hair loss at the front temple and mid-scalp areas.

The post discusses hair growth progress after using oral minoxidil and oral finasteride for four months, following a hair transplant. The user notes improved hair thickness, particularly in the mid scalp and crown areas.

A 44-year-old male is using topical minoxidil twice daily and experimenting with topical and oral melatonin for hair regrowth. A user noticed increased density on the crown and mid scalp.